Tumor cell-derived TGF-β and IL-10 dysregulate paclitaxel-induced macrophage activation

Journal of Leukocyte Biology

Volumn 69, Issue 1, 2001, Pages 129-137

  Mullins, David W ^a,b   Martins, Ryan S ^a   Burger, Carol J ^a   Elgert, Klaus D ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Immunosuppression; Interleukin 12; Nitric oxide; Prostaglandin E2; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; LYMPHOTOXIN; NITRIC OXIDE; NITRITE; PACLITAXEL; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; IN VITRO STUDY; INFLAMMATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOWN-REGULATION; DRUG INTERACTIONS; INTERLEUKIN-10; MACROPHAGE ACTIVATION; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; PACLITAXEL; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0035132826     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Taxol: An antimitotic agent with a new mechanism of action
2. Taxol: The chemistry and structure-activity relationships of a novel anticancer agent
3. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle
4. Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynecological cancers
5. Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol
6. Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer
7. Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells
8. Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production
9. Taxol-mediated changes in fibrosarcoma-induced immune cell function: Modulation of antitumor activities
10. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor-α and interleukin-1 in macrophages
11. Taxol provides a second signal for murine macrophage tumorcidical activity
12. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide
13. Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages
14. Taxol and lipopolysaccharide activation of a murine macrophage cell line and induction of similar tyrosine phosphoproteins
15. 2
16. Tumor-induced immune dysfunction: The macrophage connection
17. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene
18. Down-regulation of IL-12, not a shift from T helper-1 to T helper-2 phenotype, is responsible for impaired IFN-γ production in mammary tumor-bearing mice
19. Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages
20. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: Enhancement by PPD and LPS
21. RAW264 macrophages stably transfected with an HIV-1 LTR reprorter gene provide a sensitive bioassay for analysis of signaling pathways in macrophages stimulated with lipopolysaccharide, TNF-α or taxol
22. Rapid colorimetric assay for cellular growth and survival: Application to proliferatrion and cytotoxic assays
23. 15N]nitrate in biological fluids
24. The pathophysiology of tumor necrosis factors
25. Nitric oxide and macrophage function
26. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity
27. The respiratory burst of phagocytes
28. Involvement of inflammatory mediators in macrophage antitumor activity
29. Tumor growth modulates macrophage nitric oxide production following paclitaxel administration
30. Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation
31. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression
32. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias
33. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interlenkin 12 p40 induction